We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$29.8B
AUM Growth
+$2.61B
Cap. Flow
+$204M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.49%
Holding
319
New
30
Increased
92
Reduced
86
Closed
4

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$62.9M
2
OGN icon
Organon & Co
OGN
+$57.9M
3
MAR icon
Marriott International
MAR
+$50.4M
4
MSFT icon
Microsoft
MSFT
+$48.5M
5
NOW icon
ServiceNow
NOW
+$38.6M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$75.9M
2
ABBV icon
AbbVie
ABBV
+$59.9M
3
AAPL icon
Apple
AAPL
+$28.9M
4
MO icon
Altria Group
MO
+$19.2M
5
MRK icon
Merck
MRK
+$13M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 20.63%
3 Consumer Staples 18.28%
4 Communication Services 11.3%
5 Healthcare 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
151
Freeport-McMoran
FCX
$90B
$2.24M 0.01%
60,370
+3,200
+6% +$125K
AMT icon
152
American Tower
AMT
$80.8B
$2.14M 0.01%
7,908
+809
+11% +$206K
CVS icon
153
CVS Health
CVS
$133B
$2.1M 0.01%
25,218
+17,583
+230% +$1.44M
EMR icon
154
Emerson Electric
EMR
$83.9B
$2.08M 0.01%
21,659
-275
-1% -$25.9K
BKNG icon
155
Booking.com
BKNG
$149B
$2.08M 0.01%
23,800
-350
-1% -$32.7K
KMB icon
156
Kimberly-Clark
KMB
$36.3B
$2.08M 0.01%
15,534
+9,810
+171% +$1.31M
EW icon
157
Edwards Lifesciences
EW
$49.6B
$2.07M 0.01%
19,976
-3,560
-15% -$336K
EQIX icon
158
Equinix
EQIX
$101B
$2.03M 0.01%
2,529
– –
DHR icon
159
Danaher
DHR
$137B
$2.01M 0.01%
8,443
+1,958
+30% +$434K
C icon
160
Citigroup
C
$222B
$1.95M 0.01%
27,532
+13,362
+94% +$989K
GRFS
161
Grifois
GRFS
$5.36B
$1.93M 0.01%
111,452
– –
PAYX icon
162
Paychex
PAYX
$41.6B
$1.86M 0.01%
17,304
+12,958
+298% +$1.3M
QQQ icon
163
Invesco QQQ Trust
QQQ
$453B
$1.82M 0.01%
5,130
– –
AVB icon
164
AvalonBay Communities
AVB
$26.5B
$1.79M 0.01%
8,560
-1,775
-17% -$355K
LOW icon
165
Lowe's Companies
LOW
$117B
$1.77M 0.01%
9,143
– –
MET icon
166
MetLife
MET
$61.9B
$1.76M 0.01%
+29,426
New +$1.86M
DD icon
167
DuPont de Nemours
DD
$18.5B
$1.75M 0.01%
18,021
-239
-1% -$24K
IP icon
168
International Paper
IP
$21.6B
$1.7M 0.01%
+29,275
New +$1.67M
FISV
169
Fiserv Inc
FISV
$28.8B
$1.67M 0.01%
15,644
– –
XIFR
170
XPLR Infrastructure LP
XIFR
$1.12B
$1.66M 0.01%
21,688
+16,289
+302% +$1.16M
OMC icon
171
Omnicom Group
OMC
$21.6B
$1.62M 0.01%
+20,209
New +$1.64M
MRSH
172
Marsh
MRSH
$90.5B
$1.57M 0.01%
11,190
-1,560
-12% -$209K
XLNX
173
DELISTED
Xilinx Inc
XLNX
$1.52M 0.01%
10,524
– –
BBL
174
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$1.52M 0.01%
+25,480
New +$1.56M
GIS icon
175
General Mills
GIS
$19.1B
$1.5M 0.01%
24,679
-1,102
-4% -$68.2K
5 6
7
8 9

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Fayez Sarofim & Co held 319 positions worth $29.8B, up 9.6% from $27.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q2 2021 filing shows 30 new, 92 increased, 86 reduced and 4 closed positions. Its largest new stake was Organon & Co: 1,758,918 shares worth $53.2M. The largest sale was Chubb, an estimated $75.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q2 2021 buy was Organon & Co: 1,758,918 shares worth $53.2M.
  • Fayez Sarofim & Co added most to Procter & Gamble in Q2 2021, an estimated $62.9M increase.
  • Fayez Sarofim & Co's biggest Q2 2021 reduction was Chubb, cutting an estimated $75.9M.
  • Fayez Sarofim & Co fully exited US Bancorp in Q2 2021, selling an estimated $359K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $29.8B portfolio in Q2 2021.
  • Fayez Sarofim & Co opened 30 new positions and closed 4 in Q2 2021.
  • Fayez Sarofim & Co's portfolio value rose 9.6% quarter-over-quarter to $29.8B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2021, filed 13 Aug 2021.